Technological advances in the area of genomic medicine had led to new tests with major impact on improving disease diagnosis and effectiveness of treatments. However, the continuous growth in the use of genomic technologies has often cost implications. Using established economic models it is possible to successfully predict the costs of new treatments and assess benefits to patients in the context of available budget for health care. Moreover, this module will explore the factors that determine the effects of the rapid development of genomics on health care systems covering the role and relative influence the government, doctors and the public exert in this process . These will be analysed to assess whether clients/patients are best served by current arrangements and whether people's health matches reasonable expectations. Course participants will be encouraged to propose ways of tackling perceived shortcomings.

Sorry, there are no lists here yet. You could try:

  • Clicking My Lists from the menu. Your course enrolled lists are stored here.
  • Searching for the list using the form below:

Lists linked to Economic models and human genomics

There are currently no lists linked to this Module.